NewsBenzingaJP모건, 셀레브라이트DI 투자의견 ‘비중확대’ 유지···목표주가 15달러로 하향 조정 JP모건, 셀레브라이트DI 투자의견 ‘비중확대’ 유지···목표주가 15달러로 하향 조정 Benzinga 2026.11.13 20:09 (GMT+0) Open on Benzinga Other news Meta Internally Tests Prediction Market App 'Takes' Leerink Partners Maintains Outperform on Twist Bioscience, Lowers Price Target to $175 Microsoft Says Infrastructure Stabilizes As Queued Messages Drain And Traffic Rebalances, With No ETA For Full Recovery JP Morgan Maintains Overweight on Sea, Lowers Price Target to $132 JP Morgan Maintains Overweight on Lithium Americas, Lowers Price Target to $5 JP Morgan Maintains Overweight on Cellebrite DI, Lowers Price Target to $15
Microsoft Says Infrastructure Stabilizes As Queued Messages Drain And Traffic Rebalances, With No ETA For Full Recovery
